CSL787

N/A

Report date: 2025/07/04 20:00:55

Base Information

Drug NameCSL787
Drug Alias NameCSL787CSL-787
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaGermanyUnited Kingdom +[4
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring
Inactive CompaniesN/A
Active IndicationsBronchiectasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A